REFERENCES
Noble S, Goa KL: Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischemia and stroke. Drugs Aging 8(3):214-232, 1996
Saltiel E, Ward A: Ticlopidine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 34:222-262, 1987
Syntex: Product information, Ticlid (Ticlopidine). Mississauga, Ontario, Syntex, 1993
Gent M, Blakely JA, Easton JD, et al: The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1:1215-1220, 1989
Hass WK, Easton JD, Adams HP, et al: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. Ticlopidine Aspirin Stroke Study group. N Engl J Med 321:501-507, 1989
Deschamps JP, Lassegue A, Ottingnon Y, Vuitton D, Allemand H, Carayon P, Miguet JP: Ictère cholestique associé à la prise de ticlopidine: à propos des deux premiers cas. Gastroenterol Clin Biol 6:595-596, 1982
Biuor M, Toussaint P, Duhamel G, et al: Ticlopidine: Attrintes sanguines et hepatiques? Therapie 37:222-224, 1982
Saint Marc Girardin M-F, Cordonnier C: Ictèrecholestatique et agranulocytose dus à la ticlopidine. Gastroenterol Clin Biol 6:716-717, 1982
Eugene C, Lefebvre JF, Gury B, Quevauvilliers J: Hépatite cholestiatique: role vraisemblable de la ticlopidine. Sem Hop Paris 59:2923-2924, 1983
Pistone AM, Podesta F, Raviolo E, Testa D, Grosso B, Toselli P, Nyffeneger: Epatosteatosi colestatica di probabile origine iatrogena. Recenti Prog Med 77(4):188-190, 1986
Miyahara K, Kasahara N, Kondo Y, Imai Y, Matuzaki F: Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Jpn J Med 30:354-359, 1991
Mammarella A, Paoletti V, Moroni C, Cassone R: Ittero colestatico da ticlopidina. Clin Ter 138:45-46, 1991
Sondag D, Bader R, Claude P, Schreiber M: Hépatite à la ticlopidine: un nouveau cas. Ann Gastroenterol Hepatol 29:40-41, 1993 (letter)
Greaney JJ Jr, Hess Da, Mahoney C: Ticlopidine-induced cholestatic jaundice. Clin Pharmacol 12:398-399, 1993 (letter)
Nurhussein MA: Ticlopidine-induced prolonged cholestasis. J Am Geriatr Soc 41:1371-1372, 1993 ( letter)
Corrales JE, Herraez AM, Cejudo DR: Ictercia colestática secundaria a ticlopidina. An Med Intern (Madrid) 10(12):621- 622, 1993 ( letter)
Grimm IS, Litynski JJ: Severe cholestasis associated with ticlopidine Am J Gastroenterol 89:279-280, 1994
Yoder JD, Algozzine GJ, Hill GW: More ticlopidine-induced cholestatic jaundice. Am J Hosp Pharm 51:1821-1822, 1994 (letter)
Weber E, Donckier J: Ictère cholestatique sur ticlopidine: Un nouveau cas. Acta Clin Belg 49(6):309-310, 1994
Colvicchi F, Magnanimi S, Sebastiani F, Silvestri R, Magnanimi R: Ticlopidine-induced chronic cholestasic hepatitis: A case report. Curr Ther Res 55(8):929-931, 1994
Alvaro D, Gigliozzi A, Gaudio E, Pescarmona E, Ripani M, Peri C, Bini A, Guardia PD, Rosa TL, Riggio O, Capocaccia L: Ticlopidine-induced cholestasis: Report of two cases and experimental evidence of the drug's adverse effect in isolated perfused rat liver. Eur J Gastroenterol Hepatol 6(10):943-950, 1994
Cassidy LJ, Schuster BG, Halparin LS: Probable ticlopidine-induced cholestatic hepatitis. Ann Pharmacother 29:30-31, 1995
Valverde PR: Ticlopidine-induced granulomatous hepatitis. Ann Pharmacother 29:633, 1995 (letter)
Roy L, Plante M-A, Perreault H, Biron P: Cholestatic hepatitis: Ticlopidine suspected. The rapie 50:587-595, 1995
Naschitz JE, Khamessi R, Elias N, Yeshurun D: Ticlopidine-induced prolonged cholestasis. Clin Toxicol 33(4):379-380, 1995 (letter)
Miras Parra FJ, Gómez Jiménez FJ, Garcia Contreas T, Valverde Romera M: Hepatitis colestática por ticlopidina. Rev Enf Digest 87:414-415, 1995
Alberto L, Queiroz H, Gonzalez C, Figueira P, Barroca H, Carneiro F, Ribeiro AL: Hepatoxicidade pela ticlopidina. Arq Med 9(2):115-116, 1995
Lopez P, Castiella A, Bujanda L, Arenas JI: Hepatitis colestácica por ticlopidina. Presentación de un nuevo caso. Rev Esp Enf Digest 87(10):735-737, 1995
Pascual S, Sarrión JV, Jarque I, Arguello L, Berenguer YJ: Hepatitis colestásica y anemia por ticlopidina. Gastroenterol Hepatol 19(4):208-209, 1996
Diaz Fuenzalida A, Valdes Socin H, Laudano O, Avagnina A, Findor JA: Colestasis asociada a ticlopidina. Gastroenterol Hepatol 20(3):128-130, 1997
Bruguera M: Hepatitis colestasica asociada a ticlopidina. Gastroenterol Hepatol 20:163-164, 1997 (letter)
Yim HB, Lieu PK, Choo PW: Ticlopidine-induced cholestatic jaundice. Singapore Med J 38(3):132-133, 1997
Guzzini F, Banfi L, Gomitoni A, Marchegiani C, Novati P, Mesina M, Frigerio B: Due casi di colestasi acuta da ticlopidina. Recenti Prog Med 88(3):124-127, 1997
Rights and permissions
About this article
Cite this article
Iqbal, M., Goenka, P., Young, M.F. et al. Case Report: Ticlopidine-Induced Cholestatic Hepatitis Report of Three Cases and Review of the Literature. Dig Dis Sci 43, 2223–2226 (1998). https://doi.org/10.1023/A:1026658320577
Issue Date:
DOI: https://doi.org/10.1023/A:1026658320577